Potent De Novo Macrocyclic Peptides That Inhibit O-GlcNAc Transferase through an Allosteric Mechanism

Abstract

Glycosyltransferases are a superfamily of enzymes that are notoriously difficult to inhibit. Here we apply an mRNA display technology integrated with genetic code reprogramming, referred to as the RaPID (random non-standard peptides integrated discovery) system, to identify macrocyclic peptides with high binding affinities for O-GlcNAc transferase (OGT). These macrocycles inhibit OGT activity through an allosteric mechanism that is driven by their binding to the tetratricopeptide repeats of OGT. Saturation mutagenesis in a maturation screen using 39 amino acids, including 22 non-canonical residues, led to an improved unnatural macrocycle that is ≈40 times more potent than the parent compound (Kiapp=1.5 nM). Subsequent derivatization delivered a biotinylated derivative that enabled one-step affinity purification of OGT from complex samples. The high potency and novel mechanism of action of these OGT ligands should enable new approaches to elucidate the specificity and regulation of OGT.

Metadata

Item Type:	Article
Authors/Creators:	Alteen, Matthew G. Peacock, Hayden Meek, Richard W. (rwm512@york.ac.uk) Busmann, Jil A. Zhu, Sha Davies, Gideon J. https://orcid.org/0000-0002-7343-776X Suga, Hiroaki Vocadlo, David J.
Copyright, Publisher and Additional Information:	Funding Information: This work was supported by GlycoNet, the Canadian Glycomics Network (CD‐1), the Canadian Cancer Society Research Institute (CCSRI‐706825), and the Canadian Institutes of Health Research (PJT‐156202) to D.J.V. and the Japan Society for the Promotion of Science (JSPS) Grant‐in‐Aid for Specially Promoted Research (JP20H05618) to H.S. G.J.D. thanks the Royal Society for the Ken Murray Research Professorship and R.W.M. for the associated PDRA funding (RP\EA\180016). D.J.V. thanks the Canada Research Chairs program for support as a Tier I CRC in Chemical Biology. Funding Information: This work was supported by GlycoNet, the Canadian Glycomics Network (CD-1), the Canadian Cancer Society Research Institute (CCSRI-706825), and the Canadian Institutes of Health Research (PJT-156202) to D.J.V. and the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Specially Promoted Research (JP20H05618) to H.S. G.J.D. thanks the Royal Society for the Ken Murray Research Professorship and R.W.M. for the associated PDRA funding (RP\EA\180016). D.J.V. thanks the Canada Research Chairs program for support as a Tier I CRC in Chemical Biology. Publisher Copyright: © 2022 Wiley-VCH GmbH. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details
Keywords:	Allosteric Inhibitor,Glycosyltransferase,mRNA Display,O-GlcNAc,Peptide Macrocycle
Dates:	Accepted: 2 December 2022 Published (online): 27 December 2022 Published: 26 January 2023
Institution:	The University of York
Academic Units:	The University of York > Faculty of Sciences (York) > Chemistry (York)
Funding Information:	Funder Grant number THE ROYAL SOCIETY RP\EA\180016 THE ROYAL SOCIETY RSRP\R\210004
Depositing User:	Pure (York)
Date Deposited:	22 Feb 2023 16:10
Last Modified:	02 Apr 2025 23:25
Published Version:	https://doi.org/10.1002/anie.202215671
Status:	Published
Refereed:	Yes
Identification Number:	10.1002/anie.202215671
Related URLs:	http://www.scopus.com/inward/record.url?...
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:196718

Download

Accepted Version

Filename: Alteen_ACIE_Manuscript_Dec2_2022_plus_SI.pdf

Description: Alteen_ACIE_Manuscript_Dec2_2022-plus-SI

CLICK TO DOWNLOAD

[thumbnail of Alteen_ACIE_Manuscript_Dec2_2022-plus-SI]

CORE (COnnecting REpositories)

Potent De Novo Macrocyclic Peptides That Inhibit O-GlcNAc Transferase through an Allosteric Mechanism

Abstract

Metadata

Download

Accepted Version

Export

Statistics